Osteoclast diseases.
Osteoclasts are the only cells capable of resorbing mineralised bone, dentine and cartilage. Osteoclasts act in close concert with bone forming osteoblasts to model the skeleton during embryogenesis and to remodel it during later life. A number of inherited human conditions are known that are primarily caused by a defect in osteoclasts. Most of these are rare monogenic disorders, but others, such as the more common Paget's disease, are complex diseases, where genetic and environmental factors combine to result in the abnormal osteoclast phenotype. Where the genetic defect gives rise to ineffective osteoclasts, such as in osteopetrosis and pycnodysostosis, the result is the presence of too much bone. However, the phenotype in many osteoclast diseases is a combination of osteosclerosis with osteolytic lesions. In such conditions, the primary defect is hyperactivity of osteoclasts, compensated by a secondary increase in osteoblast activity. Rapid progress has been made in recent years in the identification of the causative genes and in the understanding of the biological role of the proteins encoded. This review discusses the known osteoclast diseases with particular emphasis on the genetic causes and the resulting osteoclast phenotype. These human diseases highlight the critical importance of specific proteins or signalling pathways in osteoclasts.
Helfrich
Miep H
MH
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, AB25 2ZD United Kingdom. m.helfrich@abdn.ac.uk
D000818:Animals; D001847:Bone Diseases; D001862:Bone Resorption; D001842:Bone and Bones / Q000473:pathology*; D002454:Cell Differentiation; D006023:Glycoproteins / Q000378:metabolism; D006801:Humans; D010001:Osteitis Deformans / Q000453:epidemiology / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D010010:Osteoclasts / Q000473:pathology* / Q000502:physiology / Q000648:ultrastructure; D010014:Osteolysis / Q000473:pathology / Q000503:physiopathology; D010022:Osteopetrosis / Q000453:epidemiology / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D053244:Osteoprotegerin; D010026:Osteosclerosis / Q000453:epidemiology / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism; D018124:Receptors, Tumor Necrosis Factor
D006023:Glycoproteins; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human